Literature DB >> 9096224

Cellular nucleic acid binding protein binds a conserved region of the 5' UTR of Xenopus laevis ribosomal protein mRNAs.

L Pellizzoni1, F Lotti, B Maras, P Pierandrei-Amaldi.   

Abstract

Vertebrate ribosomal protein mRNAs share structural features in the 5' untranslated region implicated in the control of their translation. A pyrimidine tract, at the 5' end, is considered the common cis-acting element, but the control requires also the integrity of the conserved downstream region. These sequences interact in vitro with proteins, which may represent the trans-acting factors for a common regulation. The protein that binds the pyrimidine tract has been identified as La and its binding in vitro depends on interaction with a protein factor. In the present study, by purification, microsequencing and immunoprecipitation analysis we have identified the protein that interacts with the region downstream of the pyrimidine tract as the Xenopus laevis cellular nucleic acid binding protein (CNBP). The interaction of this protein with the conserved region of various ribosomal protein (rp)-mRNAs suggests a class-specific recognition. The binding of CNBP to the target region requires the assistance of a protease-sensitive factor, that dissociates after complex formation. Some evidence suggests that this may be the same factor that assists the binding of La to the 5' untranslated region (UTR) of the rp-mRNAs. Considering that CNBP and La come in contact with two typical regions of the 5' UTR, essential for regulation, their interaction with the assisting factor may exert a modulating activity on the translational control of ribosomal protein mRNAs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9096224     DOI: 10.1006/jmbi.1996.0888

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  33 in total

1.  Identification of mushroom body miniature, a zinc-finger protein implicated in brain development of Drosophila.

Authors:  Thomas Raabe; Susanne Clemens-Richter; Thomas Twardzik; Anselm Ebert; Gertrud Gramlich; Martin Heisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-16       Impact factor: 11.205

2.  Stress puts TIA on TOP.

Authors:  Pavel Ivanov; Nancy Kedersha; Paul Anderson
Journal:  Genes Dev       Date:  2011-10-15       Impact factor: 11.361

3.  Reduction of Cellular Nucleic Acid Binding Protein Encoded by a Myotonic Dystrophy Type 2 Gene Causes Muscle Atrophy.

Authors:  Christina Wei; Lauren Stock; Christiane Schneider-Gold; Claudia Sommer; Nikolai A Timchenko; Lubov Timchenko
Journal:  Mol Cell Biol       Date:  2018-06-28       Impact factor: 4.272

4.  A conserved sequence motif in 3' untranslated regions of ribosomal protein mRNAs in nematodes.

Authors:  Ashwin Hajarnavis; Richard Durbin
Journal:  RNA       Date:  2006-08-17       Impact factor: 4.942

5.  Mutant (CCTG)n expansion causes abnormal expression of zinc finger protein 9 (ZNF9) in myotonic dystrophy type 2.

Authors:  Olayinka Raheem; Shodimu-Emmanuel Olufemi; Linda L Bachinski; Anna Vihola; Mario Sirito; Jeanette Holmlund-Hampf; Hannu Haapasalo; Yi-Ping Li; Bjarne Udd; Ralf Krahe
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

Review 6.  Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.

Authors:  Laura P W Ranum; John W Day
Journal:  Curr Neurol Neurosci Rep       Date:  2002-09       Impact factor: 5.081

Review 7.  Involvement of Dcr1 in post-transcriptional regulation of gene expression in Schizosaccharomyces pombe.

Authors:  Lise-Andree Gobeil; Pierre Plante; Mina Rohani; Marc Ouellette; Patrick Provost
Journal:  Front Biosci       Date:  2008-01-01

8.  Reduction of the rate of protein translation in patients with myotonic dystrophy 2.

Authors:  Claudia Huichalaf; Benedikt Schoser; Christiane Schneider-Gold; Bingwen Jin; Partha Sarkar; Lubov Timchenko
Journal:  J Neurosci       Date:  2009-07-15       Impact factor: 6.167

9.  ZNF9 activation of IRES-mediated translation of the human ODC mRNA is decreased in myotonic dystrophy type 2.

Authors:  Morgan A Sammons; Amanda K Antons; Mourad Bendjennat; Bjarne Udd; Ralf Krahe; Andrew J Link
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

10.  Myotonic dystrophies 1 and 2: complex diseases with complex mechanisms.

Authors:  Benedikt Schoser; Lubov Timchenko
Journal:  Curr Genomics       Date:  2010-04       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.